[1]
|
韦丽, 李虎, 胡鹏. ALT正常的慢性HBV感染者疾病进展相关危险因素[J]. 中华肝脏病杂志, 2020, 28(12): 995-998.
|
[2]
|
Zhou, J., Wang, F.-D., Wang, M.-L., et al. (2021) Antiviral Therapy for Chronic HBV Infection with Persistently Normal Alanine Aminotransferase: Controversy and Consensus. Frontiers in Medicine, 8, Article 717125.
https://doi.org/10.3389/fmed.2021.717125
|
[3]
|
Kennedy, P.T.F., Sandalova, E., Jo, J., Gill, U., Ushiro-Lumb, I., Tan, A.T., Naik, S., Foster, G.R. and Bertoletti, A. (2012) Preserved T-Cell Function in Children and Young Adults with Immune-Tolerant Chronic Hepatitis B. Gastroenterology, 143, 637-645. https://doi.org/10.1053/j.gastro.2012.06.009
|
[4]
|
Koffas, A., Petersen, J. and Kennedy, P.T. (2020) Reasons to Consider Early Treatment in Chronic Hepatitis B Patients. Antiviral Research, 177, Article ID: 104783. https://doi.org/10.1016/j.antiviral.2020.104783
|
[5]
|
Hong, Y.M. and Yoon, K.T. (2022) [Definition and Manage-ment of the Immune Tolerance Phase in Chronic Hepatitis B]. The Korean Journal of Gastroenterology, 79, 156-160. (In Korean) https://doi.org/10.4166/kjg.2022.049
|
[6]
|
Korean Association for the Study of the Liver (KASL) (2019) KASL Clinical Practice Guidelines for Management of Chronic Hepatitis B. Clinical and Molecular Hepatology, 25, 93-159. https://doi.org/10.3350/cmh.2019.1002
|
[7]
|
Terrault, N.A., Lok, A.S.F., McMahon, B.J., Chang, K.M., Hwang, J.P., Jonas, M.M., Brown Jr., R.S., Bzowej, N.H. and Wong, J.B. (2018) Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology, 67, 1560-1599. https://doi.org/10.1002/hep.29800
|
[8]
|
European Association for the Study of the Liver (2017) EASL 2017 Clini-cal Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology, 67, 370-398. https://doi.org/10.1016/j.jhep.2017.03.021
|
[9]
|
Wong, G.L.-H. (2018) Management of Chronic Hepatitis B Pa-tients in Immunetolerant Phase: What Latest Guidelines Recommend. Clinical and Molecular Hepatology, 24, 108-113. https://doi.org/10.3350/cmh.2017.0068
|
[10]
|
段梦慧, 刘学恩, 庄辉. 慢性乙型肝炎病毒感染免疫耐受期的新认识[J]. 中华肝脏病杂志, 2021, 29(3): 284-288.
https://doi.org/10.3760/cma.j.cn501113-20200629-00352
|
[11]
|
Li, Q., Zhou, Y., Huang, C., Li, W. and Chen, L. (2018) A Novel Diagnostic Algorithm to Predict Significant Liver Inflammation in Chronic Hepatitis B Virus Infection Patients with Detectable HBV DNA and Persistently Normal Alanine Transaminase. Scientific Reports, 8, Article No. 15449. https://doi.org/10.1038/s41598-018-33412-z
|
[12]
|
Gui, H.L., Wang, H., Yang, Y.H., Wu, Y.W., Zhou, H.J., Guo, S.M., Lin, L.Y., Wang, L., Cai, W., Chen, R., Guo, Q., Zhou, X.Q., Bao, S.S. and Xie, Q. (2010) Significant His-topathology in Chinese Chronic Hepatitis B Patients with Persistently High-Normal Alanine Aminotransferase. Journal of Viral Hepatitis, 17, 44-50.
https://doi.org/10.1111/j.1365-2893.2010.01270.x
|
[13]
|
周璇, 李维正, 马文婷, 薛冬英. ALT正常慢性HBV感染者肝组织病理与年龄、ALT和HBV DNA水平相关性研究[J]. 肝脏, 2019, 24(10): 1141-1144.
|
[14]
|
Yang, H.I., Yuen, M.-F., Chan, H.-L., Han, K.-H., Chen, P.-J., Kim, D.-Y., Ahn, S.-H., Chen, C.-J., Wong, V.-W. and Seto, W.-K. (2011) Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B (REACH-B): Development and Validation of a Predictive Score. The Lancet Oncology, 12, 568-574.
https://doi.org/10.1016/S1470-2045(11)70077-8
|
[15]
|
Jeon, M.Y., Kim, B.K., Lee, J.S., Lee, H.W., Park, J.Y., Kim, D.Y., Ahn, S.H., Han, K.H. and Kim, S.U. (2021) Negligible Risks of Hepatocellular Carcinoma During Bi-omarker-Defined Immune-Tolerant Phase for Patients with Chronic Hepatitis B. Clinical and Molecular Hepatology, 27, 295-304. https://doi.org/10.3350/cmh.2020.0216
|
[16]
|
Ning, H.B., Jin, H.M., Li, K., Peng, Z. and Shang, J. (2022) Analysis of Hepatic Pathological Inflammation and Fibrosis Condition and Its Influencing Factors in 721 Patients with Chronic Hepatitis B with Normal ALT. Chinese Journal of Hepatology, 30, 746-751.
|
[17]
|
Duan, M., Chi, X., Xiao, H., Liu, X. and Zhuang, H. (2021) High-Normal Alanine Aminotransferase Is an Indicator for Liver Histopathology in HBeAg-Negative Chronic Hepatitis B. Hepatology International, 15, 318-327.
https://doi.org/10.1007/s12072-021-10153-2
|
[18]
|
Zeng, Z., Hao, H., Bi, X., Lin, Y., Yang, L., Wang, S., Shen, G., Chang, M., Jiang, T., Deng, W., Lu, H., Sun, F., Lu, Y., Gao, Y., Liu, R., Xu, M., Chen, X., Hu, L., Zhang, L., Li, M. and Xie, Y. (2022) Study on Liver Histopathology of Chronic HBV Infected Patients with Different Normal ALT Values. Frontiers in Immunology, 13, Article ID: 1069752.
https://doi.org/10.3389/fimmu.2022.1069752
|
[19]
|
胡爱荣, 胡耀仁. ALT正常慢性HBV感染者不宜“全员治疗” [J]. 临床肝胆病杂志, 2021, 37(7): 1527.
|
[20]
|
Wei, S., Hu, M., Chen, H., Xie, Q., Wang, P., Li, H. and Peng, J. (2022) Effectiveness of Antiviral Treatment in HBeAg-Negative Chronic Hepatitis B Patients with Normal or Mildly El-evated Alanine Aminotransferase: A Retrospective Study. BMC Gastroenterology, 22, Article No. 387. https://doi.org/10.1186/s12876-022-02471-y
|
[21]
|
欧蔚妮, 张娜, 王笑梅, 等. 丙氨酸氨基转移酶正常或轻度升高的慢性乙型肝炎患者抗病毒疗效的影响因素[J]. 中华实验和临床感染病杂志(电子版), 2016, 10(4): 417-421.
|
[22]
|
Zhao, Q., Liu, K., Zhu, X., Yan, L., Ding, Y., Xu, Y., Lou, S., Zhao, G., Xie, Q., Gao, Y., Bao, S. and Wang, H. (2020) Anti-Viral Effect in Chronic Hepatitis B Patients with Normal or Mildly Elevated Alanine Aminotrans-ferase. Antiviral Research, 184, Article ID: 104953. https://doi.org/10.1016/j.antiviral.2020.104953
|
[23]
|
Kumada, T., Toyoda, H., Kiriyama, S., Sone, Y., Tanikawa, M., Hisanaga, Y., Kanamori, A., Atsumi, H., Takagi, M., Arakawa, T. and Fujimori, M. (2010) Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection Who Have Normal Alanine Aminotransferase Values. Journal of Medical Virology, 82, 539-545.
https://doi.org/10.1002/jmv.21686
|
[24]
|
Kim, G.-A., Lim, Y.-S., Han, S., Choi, J., Shim, J.H., Kim, K.M., Lee, H.C. and Lee, Y.S. (2018) High Risk of Hepatocellular Carcinoma and Death in Patients with Immune-Tolerant-Phase Chronic Hepatitis B. Gut, 67, 945-952.
https://doi.org/10.1136/gutjnl-2017-314904
|
[25]
|
Chu, C.-M. and Liaw, Y.-F. (2018) Prognosis of Im-mune-Tolerant Phase Chronic Hepatitis B. Gut, 67, 988.
https://doi.org/10.1136/gutjnl-2017-315603
|
[26]
|
Wu, Z., Ma, A.-L., Xie, Q., Zhang, X.-Q., Cheng, J., Zhang, D.-Z., Wang, G.-Q. and Zhao, H. (2021) Significant Histological Changes and Satisfying Antiviral Efficacy in Chronic Hepatitis B Virus Infection Patients with Normal Alanine Aminotransferase. Antiviral Therapy Decision in Chronic HBV Patients with Normal ALT. Clinics and Research in Hepatology and Gastroenterology, 45, Article ID: 101463. https://doi.org/10.1016/j.clinre.2020.05.011
|
[27]
|
Li, Q., Huang, C., Xu, W., Hu, Q. and Chen, L. (2019) A Simple Algorithm for Non-Invasive Diagnosis of Significant Liver Histological Changes in Patients with CHB and Normal or Mildly Elevated Alanine Transaminase Levels. Medicine, 98, e16429. https://doi.org/10.1097/MD.0000000000016429
|
[28]
|
张佳怡, 陈姝延, 尤红. 扩大慢性乙型肝炎初始治疗: 降低ALT治疗阈值[J]. 临床肝胆病杂志, 2023, 39(1): 29-30.
|